Provided by Tiger Trade Technology Pte. Ltd.

WUXI XDC

62.800
-1.650-2.56%
Volume:6.45M
Turnover:404.43M
Market Cap:79.00B
PE:62.68
High:64.400
Open:64.300
Low:62.000
Close:64.450
52wk High:85.500
52wk Low:24.700
Shares:1.26B
HK Float Shares:1.26B
Volume Ratio:1.91
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.002
ROE:19.76%
ROA:9.04%
PB:9.46
PE(LYR):62.68
PS:13.83

Loading ...

WuXi XDC Cayman Inc. (02268) Announces October 2025 Monthly Return, Issued Shares Reach Approximately 1.254 Billion

Bulletin Express
·
Nov 05, 2025

Goldman Sachs: WUXI XDC (02268) Maintains Strong Order Momentum with Target Price of HK$63.3

Stock News
·
Nov 05, 2025

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31, 2025

WuXi XDC (02268) Announces Changes in Issued Share Capital

Bulletin Express
·
Oct 30, 2025

WuXi XDC Completes HK$1.4 Billion Share Sale to WuXi Biologics

MT Newswires Live
·
Oct 23, 2025

WUXI XDC (02268) Issues 24.134 Million Shares Under Special Authorization

Stock News
·
Oct 23, 2025

WuXi XDC (Stock Code: 2268) Announces Completion of Connected Transaction Involving Subscription of New Shares

Bulletin Express
·
Oct 23, 2025

WuXi XDC (02268) Announces Changes in Issued Shares and Connected Subscription

Bulletin Express
·
Oct 23, 2025

GLMS SEC Maintains “Buy” Rating on WUXI XDC (02268) and Raises Earnings Forecast

Stock News
·
Oct 16, 2025

WUXI XDC Receives First Coverage with "Buy" Rating

Stock News
·
Oct 13, 2025

WuXi AppTec Continues Portfolio Streamlining: Fourth Reduction in WuXi XDC Stakes, Cumulating HK$7 Billion in Proceeds, Investment Gains Contributing Over RMB 4.3 Billion to This Year's Net Profit

Deep News
·
Oct 11, 2025

WuXi AppTec Co Ltd disposes of 30300000 shares in WuXi XDC in multiple transactions

Reuters
·
Oct 09, 2025

WUXI APPTEC Plans to Reduce Holdings in WUXI XDC, Potentially Raising Up to HK$2.4 Billion

Deep News
·
Oct 09, 2025

Biotech Stocks Jump. Immunotech up 17%; Carsgen up 14%; BRII up 6%; JW Therap up 4%; Sirnaomics up 3%

Tiger Newspress
·
Oct 06, 2025

Impressive Earnings May Not Tell The Whole Story For WuXi XDC Cayman (HKG:2268)

Simply Wall St.
·
Oct 04, 2025

China Merchants International: Limited Impact Expected from US Tariffs on Innovative Drugs for CXO Companies, Recommends Buying 3SBIO (01530) and Others

Stock News
·
Sep 30, 2025

Huaxi Securities Initiates Coverage on WUXI XDC (02268) with "Buy" Rating, Strong Capital Expenditure Adds Certainty to Future Performance Growth

Stock News
·
Sep 30, 2025

HK Movers|Biotech Stocks Rose. Laekna Up 14%; RemeGen Rose 3%; Microport Up 2%; JW Therap, Zai Lab And Lepu Up 1%

Tiger Newspress
·
Sep 29, 2025

WuXi XDC Cayman Inc. to Participate in BPD Singapore Summit, Showcasing Biopharmaceutical Innovation

Reuters
·
Sep 27, 2025

WuXi XDC Cayman Inc. Reports 62.2% Rise in Revenue and 52.7% Increase in Net Profit for H1 2025; Basic EPS Up 51.2% to RMB 0.62

Reuters
·
Sep 26, 2025